These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 16959761)

  • 1. REMATCH and beyond: the cost of treating heart failure using an implantable left ventricular assist device.
    Dembitsky WP
    Semin Cardiothorac Vasc Anesth; 2006 Sep; 10(3):253-5. PubMed ID: 16959761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
    Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
    Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
    Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac extracorporeal life support: state of the art in 2007.
    Cooper DS; Jacobs JP; Moore L; Stock A; Gaynor JW; Chancy T; Parpard M; Griffin DA; Owens T; Checchia PA; Thiagarajan RR; Spray TL; Ravishankar C
    Cardiol Young; 2007 Sep; 17 Suppl 2():104-15. PubMed ID: 18039404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic impact of mechanical cardiac assistance.
    Evans RW
    Prog Cardiovasc Dis; 2000; 43(1):81-94. PubMed ID: 10935560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Destination therapy: current results and future promise.
    Lietz K; Miller LW
    Semin Thorac Cardiovasc Surg; 2008; 20(3):225-33. PubMed ID: 19038733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular assist device: can Canada afford this?
    Carrier M
    Can J Cardiol; 2005 Nov; 21(13):1166-8. PubMed ID: 16308591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Economic aspects of implementation of the mechanical heart, "HeartMate"].
    Kolbye A; Sander Jensen KM; Aldershvile J; Hansen PB; Kjersem AM; Nielsen KS; Olsen PS; Rasmussen B; Vogelsang G
    Ugeskr Laeger; 2000 Jun; 162(26):3722-5. PubMed ID: 10925632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complications in patients with ventricular assist devices.
    Barnes K
    Dimens Crit Care Nurs; 2008; 27(6):233-41; quiz 242-3. PubMed ID: 18953188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac support devices.
    Rodger M; McRae ME; Jaffer M; Bailey B; Del Signore S
    Prog Cardiovasc Nurs; 2009 Dec; 24(4):169-80. PubMed ID: 20002342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanical assist for heart failure. Left ventricular assist devices offer a new lease on life for some people with severe heart failure.
    Harv Heart Lett; 2008 Jan; 18(5):4-5. PubMed ID: 18293530
    [No Abstract]   [Full Text] [Related]  

  • 12. The technological imperative and the battle for the hearts of America.
    Gillick MR
    Perspect Biol Med; 2007; 50(2):276-94. PubMed ID: 17468543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulatory assist devices in heart failure patients.
    Hiestand BC
    Heart Fail Clin; 2009 Jan; 5(1):55-62, vi. PubMed ID: 19026386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can the Seattle heart failure model be used to risk-stratify heart failure patients for potential left ventricular assist device therapy?
    Levy WC; Mozaffarian D; Linker DT; Farrar DJ; Miller LW;
    J Heart Lung Transplant; 2009 Mar; 28(3):231-6. PubMed ID: 19285613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developments in mechanical support as a bridge to cardiac transplant.
    Hendry P
    Can J Cardiol; 2004 Mar; 20(4):443-6. PubMed ID: 15057321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costs associated with ventricular assist device use in children.
    Mahle WT; Ianucci G; Vincent RN; Kanter KR
    Ann Thorac Surg; 2008 Nov; 86(5):1592-7. PubMed ID: 19049755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptomatic relief: left ventricular assist devices versus resynchronization therapy.
    Delgado RM; Radovancevic B
    Heart Fail Clin; 2007 Jul; 3(3):259-65. PubMed ID: 17723934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular device as destination therapy: are we there yet?
    Badiwala MV; Rao V
    Curr Opin Cardiol; 2009 Mar; 24(2):184-9. PubMed ID: 19532106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of left ventricular-assist devices in end-stage heart failure.
    Hutchinson J; Scott DA; Clegg AJ; Loveman E; Royle P; Bryant J; Colquitt JL
    Expert Rev Cardiovasc Ther; 2008 Feb; 6(2):175-85. PubMed ID: 18248272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review article: the new concept of interventional heart failure therapy--part 1: electrical therapy, treatment of CAD, fluid removal, and ventricular support.
    Thompson KA; Philip KJ; Barbagelata A; Schwarz ER
    J Cardiovasc Pharmacol Ther; 2010 Jun; 15(2):102-11. PubMed ID: 20435990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.